Alphamab Oncology (9966.HK)

HKD 7.85

(21.52%)

Inventory Summary of Alphamab Oncology

Alphamab Oncology's latest annual inventory in 2023 was 78.74 Million CNY , up 21.83% from previous year.
Alphamab Oncology's latest quarterly inventory in 2024 Q2 was 65.16 Million CNY , down 0.0% from previous quarter.
Alphamab Oncology reported annual inventory of 64.63 Million CNY in 2022, up 11.62% from previous year.
Alphamab Oncology reported annual inventory of 57.9 Million CNY in 2021, up 30.66% from previous year.
Alphamab Oncology reported quarterly inventory of 78.74 Million CNY for 2023 Q4, down 0.0% from previous quarter.
Alphamab Oncology reported quarterly inventory of 78.74 Million CNY for 2023 FY, up 21.83% from previous quarter.

Annual Inventory Chart of Alphamab Oncology (2023 - 2017)

Historical Annual Inventory of Alphamab Oncology (2023 - 2017)

Year	Inventory	Inventory Growth
2023	78.74 Million CNY	21.83%
2022	64.63 Million CNY	11.62%
2021	57.9 Million CNY	30.66%
2020	44.32 Million CNY	71.0%
2019	25.91 Million CNY	266.69%
2018	7.06 Million CNY	102.75%
2017	3.48 Million CNY	0.0%

Year	Inventory	Inventory Growth
2024 Q2	65.16 Million CNY	0.0%
2023 Q4	78.74 Million CNY	0.0%
2023 FY	78.74 Million CNY	21.83%
2023 Q2	62.93 Million CNY	0.0%
2022 Q2	75.62 Million CNY	0.0%
2022 FY	64.63 Million CNY	11.62%
2022 Q4	64.63 Million CNY	0.0%
2021 Q2	51 Million CNY	0.0%
2021 Q4	57.9 Million CNY	0.0%
2021 FY	57.9 Million CNY	30.66%
2020 Q2	32.99 Million CNY	0.0%
2020 FY	44.32 Million CNY	71.0%
2020 Q4	44.32 Million CNY	0.0%
2019 FY	25.91 Million CNY	266.69%
2019 Q4	25.91 Million CNY	0.0%
2019 Q2	20.5 Million CNY	0.0%
2018 Q4	7.06 Million CNY	0.0%
2018 FY	7.06 Million CNY	102.75%
2017 FY	3.48 Million CNY	0.0%

Peer Inventory Comparison of Alphamab Oncology

Name	Inventory	Inventory Difference
Uni-Bio Science Group Limited	36.39 Million HKD	-116.385%
CK Life Sciences Int'l., (Holdings) Inc.	1.2 Billion HKD	93.462%